Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Corilagin and 1,3,6-Tri-O-galloy-β-D-glucose: potential inhibitors of SARS-CoV-2 variants.

Physical chemistry chemical physics : PCCP - 14 Jul 2021

Binette Vincent, Côté Sébastien, Haddad Mohamed, Nguyen Phuong Trang, Bélanger Sébastien, Bourgault Steve, Ramassamy Charles, Gaudreault Roger, Mousseau Normand

Abstract excerpt

The COVID-19 disease caused by the virus SARS-CoV-2, first detected in December 2019, is still emerging through virus mutations. Although almost under control in some countries due to effective vaccines that are mitigating the worldwide pandemic, the urgency to develop additional vaccines and therapeutic treatments is imperative. In this work, the natural polyphenols corilagin and 1,3,6-tri-O-galloy-β-d-glucose...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin-Converting Enzyme 2
Share to Glucosides

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Docking Simulation

Share to Molecular Dynamics Simulation

Share to Protein Interaction Domains and Motifs

Share to SARS-CoV-2

Share to Spike Glycoprotein, Coronavirus

Share to Virus Internalization

Source

Identifiers

PMID: 34223589
DOI: 10.1039/d1cp01790j

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Corilagin and 1,3,6-Tri-O-galloy-β-D-glucose: potential inhibitors of SARS-CoV-2 variants.PMID 34223589Read ↗

Daucosterol and Beta-Sitosterol – the Future-Ready phytochemicals from Terminalia chebula to combat SARS-CoV-2Semantic proximity Read ↗

In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19Semantic proximity Read ↗

EGCG as an anti-SARS-CoV-2 agent: Preventive versus therapeutic potential against original and mutant virus.Semantic proximity Read ↗

Genetic Algorithm-Based Docking of Potent Inhibitors Against SARS-CoV-2 Main Protease: A Comparison Between Natural Products and Synthetic Drugs.Semantic proximity Read ↗

Computational studies on the interaction of SARS-CoV-2 Omicron SGp RBD with human receptor ACE2, limonin and glycyrrhizic acid.Semantic proximity Read ↗

Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations.Semantic proximity Read ↗

The natural tannins oligomeric proanthocyanidins and punicalagin are potent inhibitors of infection by SARS-CoV-2 in vitroSemantic proximity Read ↗

Network pharmacology, molecular docking, and dynamics analyses to predict the antiviral activityof ginger constituents against coronavirus infectionSemantic proximity Read ↗

Therapeutic Role of Phytophenol Gallic Acid for the Cure of COVID-19 Pathogenesis.Semantic proximity Read ↗

The Pan-African Natural Products Library Compounds Oleanolic Acid, Poinsettifolin B, and Rhuschalcone III Disrupt SARS-CoV-2 Spike-Host ACE2 Interactions and SARS-CoV-2 ReplicationSemantic proximity Read ↗

Epigallocatechin Gallate from Green Tea Effectively Blocks Infection of SARS-CoV-2 and New Variants by Inhibiting Spike Binding to ACE2 ReceptorSemantic proximity Read ↗

In Silico and In Vitro Studies of Alchemilla viridiflora Rothm-Polyphenols' Potential for Inhibition of SARS-CoV-2 Internalization.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.